Zegomib

Zegomib (Bortezomib) is an injectable prescription medicine used in certain cancer treatments. It belongs to a class of drugs known as proteasome inhibitors. This product is supplied as a sterile powder for reconstitution. Always use under medical supervision for best results.

Zegomib is primarily used to treat multiple myeloma and mantle cell lymphoma in adult patients. It works by interfering with cancer cell growth and survival. Healthcare providers may also prescribe it for other conditions within its approved indications. This medication is administered by a healthcare professional in a clinical setting.

Patients receiving Zegomib may experience effects such as fatigue, nausea, or reduced appetite. Some individuals report peripheral neuropathy, which involves tingling or numbness in the hands or feet. These effects vary widely between patients and should be monitored by a healthcare team.

Zegomib is a potent medication that requires careful handling and administration by trained professionals. Keep this product refrigerated and protected from light until use. Always follow sterile reconstitution procedures to maintain product integrity. Discard any unused portion properly as directed.

Zegomib may interact with other medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers. Combining it with certain drugs could alter its effectiveness or increase side effects. Always inform your healthcare provider about all medications you are taking before starting Zegomib therapy.